Pooling 54 prospective and retrospective cohort studies encompassing 1,833,267 participants and 346,034 deaths, this meta-analysis quantifies Mediterranean diet (MD) adherence against all-cause mortality using validated scoring instruments. Each single-point increment in MD adherence score yielded a pooled relative risk of 0.96 (95% CI: 0.95–0.97), a statistically significant 4% risk reduction, with evidence certainty rated moderate via the NUTRIGRADE framework. Follow-up periods ranged from 2 to 60 years across geographically diverse populations.
The 4%-per-point finding deserves careful framing. Most validated MD scores span roughly 0–55 points, meaning the difference between low and high adherence could translate to a 20–35% mortality reduction — a magnitude consistent with earlier landmark meta-analyses, including Sofi et al. (2010) and Dinu et al. (2018), which reported roughly 8–11% reductions per two-point increments. This work extends that evidence base considerably in sample size, strengthening confidence that the association is robust across ethnicities and non-Mediterranean populations where generalizability has historically been questioned.
Critical limitations persist: all included studies are observational, meaning dietary assessment relies on self-report susceptible to recall and social-desirability bias, and residual confounding by socioeconomic status and physical activity remains inherent. The moderate — not high — certainty rating reflects genuine heterogeneity concerns. Still, with nearly 1.9 million participants, this meta-analysis moves the MD-longevity link closer to actionable public health guidance than any single prior effort. For adults seeking evidence-based dietary frameworks, it represents strong confirmatory, not paradigm-shifting, evidence.
